La lgica es la siguiente: sin proteccin de patentes, ninguna empresa invertira miles de millones en investigacin si otra compaa pudiera copiar el medicamento inmediatamente sin haber asumido el riesgo econmico
A major potential advantage of the peptide is that due to its apparent GHRH receptor specificity, it may not induce any significant change in the levels of other endocrine markers such as prolactin, insulin, cortisol, glucose, or thyroid hormones
Since it was manufactured as a drug for diabetes patients, it primarily works to increase the level of insulin that your body produces
In the pivotal STEP-1 trial , participants receiving once-weekly Semaglutide injections lost an average of 14.9% of their baseline body weight over 68 weeks , compared to just 2.4% in the placebo group
For detailed guidance on how quickly semaglutide starts working , check our timeline guide
A: We prioritize quality and transparency